[Ototoxicity of erythromycin]. 1979

W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D034381 Hearing Loss A general term for the complete or partial loss of the ability to hear from one or both ears. Deafness, Transitory,Hearing Impairment,Hearing Loss, Transitory,Hypoacusis,Transitory Hearing Loss,Deafnesses, Transitory,Hypoacuses,Loss, Hearing,Loss, Transitory Hearing,Transitory Deafness,Transitory Deafnesses,Transitory Hearing Losses

Related Publications

W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
September 1982, The Medical journal of Australia,
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
July 2003, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology,
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
February 1980, The Journal of otolaryngology,
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
May 1978, Lancet (London, England),
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
June 1983, Mayo Clinic proceedings,
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
February 2007, Prescrire international,
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
March 1981, American journal of obstetrics and gynecology,
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
January 1979, Acta clinica Belgica,
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
February 1981, Drug intelligence & clinical pharmacy,
W F van Marion, and J W van der Meer, and M W Kalff, and S M Schicht, and E A Baarsma
February 1993, The American journal of medicine,
Copied contents to your clipboard!